The MarketWatch News Department was not involved in the creation of this content. HANGZHOU, China and SHANGHAI and BOSTON, Dec. 10, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter ...

Tonix Pharmaceuticals has secured a presentation slot at the prestigious BIO CEO & Investor Conference, which can enhance visibility and investor interest in the company. The company’s product ...

Nuvation Bio (NUVB) just signed an exclusive license and collaboration deal with Japan based Eisai that hands Eisai ...

CHATHAM, N.J., May 30, 2023 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that Seth Lederman, M.D., ...

This news release contains certain forward-looking statements relating to STARJEMZA ® /BAT2206 or the product pipelines in general of Bio-Thera Solutions and Hikma. Readers are strongly cautioned that ...

Processa Pharmaceuticals, Inc. announced its participation in the 2025 BIO International Convention from June 16-19 in Boston, where key executives, including CEO Georg Ng and President of R&D Dr.

MUNICH, DE / ACCESS Newswire / May 12, 2025 / Secarna Pharmaceuticals GmbH & Co. KG, a company redefining the discovery and development of best-in-class oligonucleotide therapeutics, today announced ...

The global bio-pharmaceutical market is projected to surge to approximately 1,400 trillion won in about two years. Bio-pharmaceuticals refer to medicines made from biological materials such as human ...

The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study in neuropathic pain, and finalizes filings for SKNY acquisition. MIAMI, FL ...

GUANGZHOU, China, Oct. 9, 2025 /PRNewswire/ -- Bio-Thera Solutions (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, today ...

Gilead Sciences secured the rights to Sprint Bioscience’s preclinical oncology program for up to $400 million. Iolyx Therapeutics announced a strategic partnership with Laboratoires Théa, valued at up ...